BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 6, 2019

View Archived Issues

FDA nod for soft exosuit from Rewalk, Wyss, to drive company to profitability in next few years

Rewalk Robotics Ltd. received U.S. FDA clearance for its second robotic medical device for people with lower limb disability. Known as the Restore soft exosuit system, it is cleared for use as part of physical therapy to aid stroke survivors with mobility problems. The Israeli company, which has additional headquarters in Marlborough, Mass., and Berlin, anticipates that the Restore soft exosuit may outstrip its existing Rewalk Personal 6.0 robotic exoskeleton for home use by patients with paralysis from spinal cord injury – and substantially contribute to a path to breakeven and profitability in the next couple of years. Read More

U.S. lawmakers seek way to undo SCOTUS 'patent mess'

Read More

Panel unanimously backs class II for surgical staplers

Read More

Virtual platform provides new path for health in Pakistan

KARACHI, Pakistan – Pakistan is running short of women doctors. That's not due to a lack of medical education facilities – 70% of all medical students are women – but because many of them leave midway through their careers. The Muslim-majority country now is looking to new medical technologies and telemedicine to address this issue. One startup that launched in 2017, Sehat Kahani, is relying on telemedicine to expand the reach of health care by, in large part, tapping into this pool of medical talent. Read More

HMP delivers insights into microbiome changes, stability

Read More

Daily M&A

Read More

Regulatory front

Read More

Appointments and advancements

Read More

Other news to note

Read More

Product clinical data for June 5, 2019

Read More

Product regulatory actions for June 5, 2019

Read More

BioWorld MedTech's Orthopedics Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 17, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • EU flag vector

    European Commission floats multiple fixes for MDR, IVDR

    BioWorld MedTech
    The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing